about
Current understanding of metformin effect on the control of hyperglycemia in diabetesTowards a systems approach for chronic diseases, based on health state modeling.Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex.Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production.Metformin; a review of its history and future: from lilac to longevity.Quantitative Analysis of NAD Synthesis-Breakdown Fluxes.
P2860
Q26770236-BFDD2F66-F51B-409E-B876-916E6E47369DQ30491730-AB31C678-8E26-4965-9821-E5A322E9FD3AQ33946957-69CDF573-8992-45D1-9BAC-6E616E2000ECQ35055641-DE64B1E5-CAD2-4E1C-8AE4-BD972B083E96Q36898203-23146929-E3CC-4D16-84EA-DBA653C7F858Q38774878-80D90297-2E18-4295-A212-F49744C14ACDQ52568842-0FAA49CB-CA59-4451-9F34-0AA9F054455F
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Potential biomarker of metformin action.
@ast
Potential biomarker of metformin action.
@en
type
label
Potential biomarker of metformin action.
@ast
Potential biomarker of metformin action.
@en
prefLabel
Potential biomarker of metformin action.
@ast
Potential biomarker of metformin action.
@en
P2093
P2860
P356
P1476
Potential biomarker of metformin action.
@en
P2093
Fredric E Wondisford
Sally Radovick
Shumei Meng
P2860
P304
P356
10.1530/JOE-14-0084
P407
P577
2014-03-17T00:00:00Z